Targacept , Nasdaq: TRGT
Developing a new class of drugs to treat Alzheimer's and cognitive loss
Industry: Health Care
First Day Return: -3.8%
Industry: Health Care
TRGT
Developing a new class of drugs to treat Alzheimer's and cognitive loss
| IPO Data | |
|---|---|
| IPO File Date | 01/17/2006 |
| Offer Price | $9.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $45 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 04/11/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $45 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Winston-Salem, NC, United States |
| Founded | 1997 |
| Employees at IPO | 74 |
| Website www.targacept.com | |
IPO News for Targacept
Targacept (TRGT) Performance
